Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lahlou, N.
Right arrow Articles by Bouchard, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lahlou, N.
Right arrow Articles by Bouchard, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 5, 1190-1193, May 1999
© 1999 European Society of Human Reproduction and Embryology

Main inhibitor of follicle stimulating hormone in the luteal–follicular transition: inhibin A, oestradiol, or inhibin B?

N. Lahlou1,3, N. Chabbert-Buffet2, S. Christin-Maitre2, E. Le Nestour2, M. Roger1 and P. Bouchard2

1 INSERM U 342, Hôpital Saint-Vincent-de-Paul,82 av Denfert-Rochereau, 75014 Paris and 2 Service d'Endocrinologie, Hôpital Saint-Antoine, Paris, France

The roles of oestradiol, inhibin A and inhibin B in the luteal–follicular transition were assessed by means of specific assays. Six premenopausal women were studied during a control and then a cycle treated with percutaneous oestradiol 0.1 mg/day from day 10 after the luteinizing hormone (LH) surge until day 4 of the following cycle. Inhibin A concentrations decreased similarly in control and treated cycles from day –5 to day 2, then increased in control cycle to 23.3 ± 3.4 pg/ml on day 10 (mean ± SEM). They remained low until day 5 in treated cycles and were lower than controls on day 10 (P < 0.01). Follicle stimulating hormone (FSH) concentrations increased on day 1 in controls and on day 5 in treated cycles when oestradiol concentration fell abruptly. Inhibin B concentrations remained low until day 1 in controls and day 4 in treated cycles. In both, inhibin B concentrations increased 1 day after FSH, peaking at 160 pg/ml. FSH concentrations began to plateau when inhibin B concentrations were >100 pg/ml and oestradiol concentrations below 200 pmol/l. These data suggest that inhibin A is not responsible for FSH suppression in the luteal phase and that the negative control of FSH shifts from oestradiol in the luteal phase to inhibin B in the mid-follicular phase.

Key words: FSH/inhibin A/inhibin B/menstrual cycle/oestradiol

3 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
I. Cedrin-Durnerin, B. Bstandig, I. Parneix, V. Bied-Damon, C. Avril, C. Decanter, and J.N. Hugues
Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol
Hum. Reprod., January 1, 2007; 22(1): 109 - 116.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I. Cedrin-Durnerin, N. Massin, J. Galey-Fontaine, H. Bry-Gauillard, M. Roger, N. Lahlou, and J.N. Hugues
Timing of FSH administration for ovarian stimulation in normo-ovulatory women: comparison of an early or a mid follicular phase initiation of a short-term treatment
Hum. Reprod., November 1, 2006; 21(11): 2941 - 2947.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Soriano-Guillen, V. Mitchell, J.-C. Carel, P. Barbet, M. Roger, and N. Lahlou
Activating Mutations in the Luteinizing Hormone Receptor Gene: A Human Model of Non-Follicle-Stimulating Hormone-Dependent Inhibin Production and Germ Cell Maturation
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3041 - 3047.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
H. Lefevre, C. Bouvattier, N. Lahlou, C. Adamsbaum, P. Bougneres, and J.-C. Carel
Prepubertal gynecomastia in Peutz-Jeghers syndrome: incomplete penetrance in a familial case and management with an aromatase inhibitor
Eur. J. Endocrinol., February 1, 2006; 154(2): 221 - 227.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, A. Falorni, A. E. Taylor, K. A. Martin, and J. E. Hall
Selective Theca Cell Dysfunction in Autoimmune Oophoritis Results in Multifollicular Development, Decreased Estradiol, and Elevated Inhibin B Levels
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3069 - 3076.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, J. E. Hall, J. M. Adams, and A. E. Taylor
Relationship of Estradiol and Inhibin to the Follicle-Stimulating Hormone Variability in Hypergonadotropic Hypogonadism or Premature Ovarian Failure
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 826 - 830.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Miro and L.J. Aspinall
The onset of the initial rise in follicle-stimulating hormone during the human menstrual cycle
Hum. Reprod., January 1, 2005; 20(1): 96 - 100.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. A. Klein, B. S. Houmard, K. R. Hansen, T. K. Woodruff, P. M. Sluss, W. J. Bremner, and M. R. Soules
Age-Related Analysis of Inhibin A, Inhibin B, and Activin A Relative to the Intercycle Monotropic Follicle-Stimulating Hormone Rise in Normal Ovulatory Women
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2977 - 2981.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Lahlou, I. Fennoy, J.-C. Carel, and M. Roger
Inhibin B and Anti-Mullerian Hormone, But Not Testosterone Levels, Are Normal in Infants with Nonmosaic Klinefelter Syndrome
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1864 - 1868.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. Vasseur, P. Rodien, I. Beau, A. Desroches, C. Gerard, L. de Poncheville, S. Chaplot, F. Savagner, A. Croue, E. Mathieu, et al.
A Chorionic Gonadotropin-Sensitive Mutation in the Follicle-Stimulating Hormone Receptor as a Cause of Familial Gestational Spontaneous Ovarian Hyperstimulation Syndrome
N. Engl. J. Med., August 21, 2003; 349(8): 753 - 759.
[Full Text] [PDF]


Home page
Hum ReprodHome page
J. Kwee, M.W. Elting, R. Schats, P.D. Bezemer, C.B. Lambalk, and J. Schoemaker
Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study
Hum. Reprod., July 1, 2003; 18(7): 1422 - 1427.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, Y. L. Pagan, P. C. Smith, K. B. Rado, and J. E. Hall
Control of Follicle-Stimulating Hormone by Estradiol and the Inhibins: Critical Role of Estradiol at the Hypothalamus during the Luteal-Follicular Transition
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1766 - 1771.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. Y.K. Yong, D. T. Baird, K.J. Thong, A. S. McNeilly, and R. A. Anderson
Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation
Hum. Reprod., January 1, 2003; 18(1): 35 - 44.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. Welt, Y. Sidis, H. Keutmann, and A. Schneyer
Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium
Experimental Biology and Medicine, October 1, 2002; 227(9): 724 - 752.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Eldar-Geva, E.J. Margalioth, A. Ben-Chetrit, M. Gal, D.M. Robertson, D.L. Healy, Y.Z. Diamant, and I.M. Spitz
Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders
Hum. Reprod., September 1, 2002; 17(9): 2331 - 2337.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Fawzy, R.F. Harrison, P.G. Knight, N. Groome, A. Anderson, W.R. Robertson, and A. Lambert
The effect of gonadotrophins with differing LH/FSH ratios on the secretion of the various species of inhibin in women receiving IVF
Hum. Reprod., June 1, 2001; 16(6): 1092 - 1097.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A.L. Mikkelsen, A.-M. Andersson, N.E. Skakkebak, and S. Lindenberg
Basal concentrations of oestradiol may predict the outcome of in-vitro maturation in regularly menstruating women
Hum. Reprod., May 1, 2001; 16(5): 862 - 867.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Coutant, S. Lumbroso, R. Rey, N. Lahlou, M. Venara, S. Rouleau, C. Sultan, and J.-M. Limal
Macroorchidism due to Autonomous Hyperfunction of Sertoli Cells and Gs{{alpha}} Gene Mutation: An Unusual Expression of McCune-Albright Syndrome in a Prepubertal Boy
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1778 - 1781.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M.-L. Kottler, S. Chauvin, N. Lahlou, C. E. Harris, C. J. Johnston, J.-P. Lagarde, P. Bouchard, N. R. Farid, and R. Counis
A New Compound Heterozygous Mutation of the Gonadotropin-Releasing Hormone Receptor (L314X, Q106R) in a Woman with Complete Hypogonadotropic Hypogonadism: Chronic Estrogen Administration Amplifies the Gonadotropin Defect
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3002 - 3008.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
A.L. Mikkelsen, S. Smith, and S. Lindenberg
Impact of oestradiol and inhibin A concentrations on pregnancy rate in in-vitro oocyte maturation
Hum. Reprod., August 1, 2000; 15(8): 1685 - 1690.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.